Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending December 14, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
On December 12, 2006, Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("the GSK Trust"), transferred 3,000 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The Company was advised of these transactions on December 13, 2006.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust where all employees or former employees are potential beneficiaries. Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) hold interests in the shares held in the GSK Trust in the same capacity as other employees. The transaction was notified in accordance with Disclosure Rule 3.1.4R(1)(b).
Key Facts for Investor Verification
- Transaction Type: Transfer of 3,000 Ordinary Shares from the GSK Trust to employee plan participants.
- Transaction Date: December 12, 2006.
- Plan Involved: SmithKline Beecham Employee Share Option Plan 1991.
- Directors with Interest: Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop have interests in the trust shares.
- Financial Data: No financial metrics are included in this specific filing.